Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for alzheimer's disease

Journal of the International Neuropsychological Society

Volumn 20, Issue 4, 2014, Pages 422-433

  Okonkwo, Ozioma C ^a,b   Oh, Jennifer M ^a,b   Koscik, Rebecca ^b   Jonaitis, Erin ^b   Cleary, Caitlin A ^a,b   Dowling, N Maritza ^b   Bendlin, Barbara B ^a,b   Larue, Asenath ^b   Hermann, Bruce P ^b   Barnhart, Todd E ^b   Murali, Dhanabalan ^b   Rowley, Howard A ^b   Carlsson, Cynthia M ^a,b   Gallagher, Catherine L ^a,b   Asthana, Sanjay ^a,b   Sager, Mark A ^b   Christian, Brad T ^b   Johnson, Sterling C ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Amyloid; Family history of AD; FDG; FMRI; Longitudinal cognitive decline; Preclinical AD

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; OXYGEN;

ADULT; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BLOOD; BRAIN; COGNITION DISORDERS; COMPLICATION; FEMALE; GENETICS; HUMAN; IMAGE PROCESSING; LONGITUDINAL STUDY; MALE; METABOLISM; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; SCINTISCANNING; VASCULARIZATION;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; OXYGEN; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 84897089318     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617714000113     Document Type: Article

References (65)

1. Alzheimer's Association. (2012). 2012 Alzheimer's disease facts and figures. Alzheimer's Dementia, 8(2), 131-168. doi:10.1016/ j.jalz.2012.02.001
2. Benedict, R.H.B. (1997). Brief Visuospatial Memory Test-Revised. Odessa, FL: Psychological Assessment Resources, Inc
3. Benton, A.L. (1994). Neuropsychological assessment. Annual Review of Psychology, 45, 1-23. doi:10.1146/annurev.ps.45.020194. 000245
4. Benton, A.L., Hamsher, K. Sivan, A.B. (1976). Multilingual Aphasia Examination. Iowa City, IA: AJA Associates
5. Blacker, D., Lee, H., Muzikansky, A., Martin, E.C., Tanzi, R., McArdle, J.J., y Albert, M. (2007). Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Archives of Neurology, 64(6), 862-871. doi:10.1001/ archneur.64.6.862
6. Buckner, R.L., Snyder, A.Z., Shannon, B.J., LaRossa, G., Sachs, R., Fotenos, A.F., y Mintun, M.A. (2005). Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between Default activity, amyloid, and memory. Journal of Neuroscience, 25(34), 7709-7717. doi:10.1523/ JNEUROSCI.2177-05.2005
7. Cairns, N.J., Ikonomovic, M.D., Benzinger, T., Storandt, M., Fagan, A.M., Shah, A.R., y Morris, J.C. (2009). Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: A case report. Archives of Neurology, 66(12), 1557-1562. doi:10.1001/archneurol.2009.279
8. Chetelat, G. (2013). Alzheimer disease: Abeta-independent processes-rethinking preclinical AD. Nature Reviews Neurology, 9(3), 123-124. doi:10.1038/nrneurol.2013.21
9. Che'telat, G., La Joie, R., Villain, N., Perrotin, A., de La Sayette, V., Eustache, F. Vandenberghe, R. (2013). Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. Neuroimage: Clinical, 2, 356-365. doi:http://dx.doi.org/10.1016/j.nicl.2013.02. 006
10. Christian, B.T., Vandehey, N.T., Floberg, J.M. Mistretta, C.A. (2010). Dynamic PET denoising with HYPR processing. Journal of Nuclear Medicine, 51(7), 1147-1154. doi:10.2967/ jnumed.109.073999
11. Corder, E.H., Ghebremedhin, E., Taylor, M.G., Thal, D.R., Ohm, T.G. Braak, H. (2004). The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: Modification by age, sex, and APOE polymorphism. Annals of the New York Academy of Sciences, 1019, 24-28. doi:10.1196/annals.1297.005
12. Desikan, R.S., McEvoy, L.K., Thompson, W.K., Holland, D., Brewer, J.B., Aisen, P.S.,yDale, A.M. (2012). Amyloid-beta - Associated clinical decline occurs only in the presence of elevated P-Tau. Archives of Neurology, 69(6), 709-713. doi:10.1001/ archneurol.2011.3354
13. Drachman, D.A. (2006). Aging of the brain, entropy, and Alzheimer disease. Neurology, 67(8), 1340-1352. doi:10.1212/01.wnl. 0000240127.89601.83
14. Elias, M.F., Beiser, A., Wolf, P.A., Au, R., White, R.F. D'Agostino, R.B. (2000). The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Archives of Neurology, 57(6), 808-813
15. Ewers, M., Insel, P., Jagust, W.J., Shaw, L., Trojanowski, J.Q., Aisen, P., y Weiner, M.W. (2012). CSF biomarker and PIBPET-derived beta-Amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cerebral Cortex, 22(9), 1993-2004. doi:10.1093/cercor/bhr271
16. Floberg, J.M., Mistretta, C.A., Weichert, J.P., Hall, L.T., Holden, J.E. Christian, B.T. (2012). Improved kinetic analysis of dynamic PET data with optimized HYPR-LR. Medical Physics, 39(6), 3319-3331. doi:10.1118/1.4718669
17. Folstein, M.F., Folstein, S.E. McHugh, P.R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198
18. Heaton, R.K., Chelune, G.J., Talley, J.L., Kay, G.G. Curtiss, G. (1993). Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources, Inc
19. Hedden, T., Oh, H., Younger, A.P. Patel, T.A. (2013). Metaanalysis of amyloid-cognition relations in cognitively normal older adults. Neurology, 80(14), 1341-1348. doi:10.1212/ WNL.0b013e31828ab35d
20. Huijbers, W., Vannini, P., Sperling, R.A.,, C.M.P., Cabeza, R. Daselaar, S.M. (2012). Explaining the encoding/retrieval flip: Memory-related deactivations and activations in the posteromedial cortex. Neuropsychologia, 50(14), 3764-3774. doi:10.1016/j.neuropsychologia.2012.08.021
21. Jack, C.R., Jr., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner,M.W., Aisen, P.S.,yTrojanowski, J.Q. (2013). Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurology, 12(2), 207-216. doi:10.1016/S1474-4422(12)70291-0
22. Jack, C.R., Jr., Knopman, D.S., Jagust, W.J., Shaw, L.M., Aisen, P.S., Weiner, M.W., y Trojanowski, J.Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, 9(1), 119-128. doi:10.1016/S1474-4422(09)70299-6
23. Jack, C.R., Jr., Lowe, V.J., Weigand, S.D., Wiste, H.J., Senjem, M.L., Knopman, D.S., y Petersen, R.C. (2009). Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: Implications for sequence of pathological events in Alzheimer's disease. Brain, 132(Pt 5), 1355-1365. doi:10.1093/ brain/awp062
24. Jagust, W.J., Bandy, D., Chen, K., Foster, N.L., Landau, S.M., Mathis, C.A.,yKoeppe, R.A. (2010). The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's Dementia, 6(3), 221-229. doi:10.1016/ j.jalz.2010.03.003
25. Johnson, S.C., Schmitz, T.W., Moritz, C.H., Meyerand, M.E., Rowley, H.A., Alexander, A.L., y Alexander, G.E. (2006). Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment. Neurobiology of Aging, 27(11), 1604-1612. doi:10.1016/j.neurobiolaging.2005.09. 017
26. Kaplan, E., Goodglass, H. Weintraub, S. (1983). Boston Naming Test. Philadelphia: Lea Febiger
27. Kawas, C.H., Corrada, M.M., Brookmeyer, R., Morrison, A., Resnick, S.M., Zonderman, A.B. Arenberg, D. (2003). Visual memory predicts Alzheimer's disease more than a decade before diagnosis. Neurology, 60(7), 1089-1093
28. Landau, S.M., Harvey, D., Madison, C.M., Koeppe, R.A., Reiman, E.M., Foster, N.L.,yJagust, W.J. (2011). Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of Aging, 32(7), 1207-1218. doi:10.1016/j.neurobiolaging.2009.07.002
29. Landau, S.M., Harvey, D., Madison, C.M., Reiman, E.M., Foster, N.L., Aisen, P.S., y Jagust, W.J. (2010). Comparing predictors of conversion and decline in mild cognitive impairment. Neurology, 75(3), 230-238. doi:10.1212/WNL. 0b013e3181e8e8b8
30. Landau, S.M., Mintun, M.A., Joshi, A.D., Koeppe, R.A., Petersen, R.C., Aisen, P.S., y Jagust, W.J. (2012). Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of Neurology, 72(4), 578-586. doi:10.1002/ana.23650
31. Leech, R. Sharp, D.J. (2013). The role of the posterior cingulate cortex in cognition and disease. Brain. doi:10.1093/brain/awt162
32. Lim, Y.Y., Ellis, K.A., Pietrzak, R.H., Ames, D., Darby, D., Harrington, K.,yMaruff, P. (2012). Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology, 79(16), 1645-1652. doi:10.1212/WNL. 0b013e31826e9ae6
33. Lo, R.Y., Hubbard, A.E., Shaw, L.M., Trojanowski, J.Q., Petersen, R.C., Aisen, P.S.,yJagust, W.J. (2011). Longitudinal change of biomarkers in cognitive decline. Archives of Neurology, 68(10), 1257-1266. doi:10.1001/archneurol.2011. 123
34. Maldjian, J.A., Laurienti, P.J., Kraft, R.A. Burdette, J.H. (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage, 19, 1233-1239. doi: S1053811903001691 [pii]
35. Manly, J.J., Schupf, N., Tang, M.X. Stern, Y. (2005). Cognitive decline and literacy among ethnically diverse elders. Journal of Geriatric Psychiatry and Neurology, 18(4), 213-217. doi:10.1177/0891988705281868
36. Morris, J.C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43, 2412-2414
37. Morris, J.C., Roe, C.M., Grant, E.A., Head, D., Storandt, M., Goate, A.M., y Mintun, M.A. (2009). Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Archives of Neurology, 66(12), 1469-1475. doi:10.1001/archneurol.2009.269
38. Mosconi, L., Mistur, R., Switalski, R., Brys, M., Glodzik, L., Rich, K., y de Leon, M.J. (2009). Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology, 72(6), 513-520. doi:10.1212/ 01.wnl.0000333247.51383.43
39. O'Brien, J.L., O'Keefe, K.M., LaViolette, P.S., DeLuca, A.N., Blacker, D., Dickerson, B.C. Sperling, R.A. (2010). Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology, 74(24), 1969-1976. doi:10.1212/ WNL.0b013e3181e3966e
40. Okonkwo, O.C., Xu, G., Dowling, N.M., Bendlin, B.B., Larue, A., Hermann, B.P., y Johnson, S.C. (2012). Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-Aged adults. Neurology, 78(22), 1769-1776. doi:10.1212/WNL.0b013e3182583047
41. Okonkwo, O.C., Xu, G., Oh, J.M., Dowling, N.M., Carlsson, C.M., Gallagher, C.L.,yJohnson, S.C. (2012). Cerebral blood flow is diminished in asymptomatic middle-Aged adults with maternal history of Alzheimer's disease. Cerebral Cortex [Epub ahead of print].
42. Price, J.C., Klunk, W.E., Lopresti, B.J., Lu, X., Hoge, J.A., Ziolko, S.K., y Mathis, C.A. (2005). Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. Journal of Cerebral Blood Flow and Metabolism, 25(11), 1528-1547. doi:10.1038/sj.jcbfm.9600146
43. Rami, L., Sala-Llonch, R., Sole-Padulles, C., Fortea, J., Olives, J., Llado, A.,yMolinuevo, J.L. (2012). Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease. Journal of Alzheimer's Disease, 31(3), 517-526. doi:10.3233/JAD-2012-120223
44. Reitan, R. Wolfson, D. (1993). The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation. Tucson: Neuropsychology 6p
45. Rentz, D.M., Locascio, J.J., Becker, J.A., Moran, E.K., Eng, E., Buckner, R.L.,yJohnson, K.A. (2010). Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology, 67(3), 353-364. doi:10.1002/ana.21904
46. Resnick, S.M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D.P.,y Wong, D.F. (2010). Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology, 74(10), 807-815. doi:10.1212/WNL.0b013e3181d3e3e9
47. Sager, M.A., Hermann, B. La Rue, A. (2005). Middle-Aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Journal of Geriatric Psychiatry and Neurology, 18(4), 245-249. doi:10.1177/0891988705281882
48. Schmidt, M. (1996). Rey Auditory Verbal Learning Test: A handbook. Torrance, CA: Western Psychological Services
49. Sheline, Y.I., Morris, J.C., Snyder, A.Z., Price, J.L., Yan, Z., D'Angelo, G., y Mintun, M.A. (2010). APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. Journal of Neuroscience, 30(50), 17035-17040. doi:10.1523/JNEUROSCI.3987-10.2010
50. Snitz, B.E., Weissfeld, L.A., Lopez, O.L., Kuller, L.H., Saxton, J., Singhabahu, D.M., y Dekosky, S.T. (2013). Cognitive trajectories associated with beta-Amyloid deposition in the oldest-old without dementia. Neurology, 80, 1378-1384. doi:10.1212/ WNL.0b013e31828c2fc8
51. Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., y Phelps, C.H. (2011). Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on Diagnostic guidelines for Alzheimer's disease. Alzheimer's Dementia, 7(3), 280-292. doi:10.1016/ j.jalz.2011.03.003
52. Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurology, 11(11), 1006-1012. doi:10.1016/ S1474-4422(12)70191-6
53. Strauss, E., Sherman, E.M.S. Spreen, O. (2006). A compendium of neuropsychological tests (3rd ed). Oxford: Oxford University 6p
54. Trenerry, M., Crosson, B., DeBoe, J. Leber, L. (1989). Stroop Neuropsychological Screening Test. Odessa, FL: Psychological Assessment Resources, Inc
55. Vannini, P., O'Brien, J., O'Keefe, K., Pihlajamaki, M., Laviolette, P. Sperling, R.A. (2011). What goes down must come up: Role of the posteromedial cortices in encoding and retrieval. Cerebral Cortex, 21(1), 22-34. doi:10.1093/cercor/bhq051
56. Villemagne, V.L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K.A., Salvado, O., y Masters, C.L. (2013). Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study. Lancet Neurology, 12(4), 357-367. doi:10.1016/S1474-4422(13)70044-9
57. Vina, J. Lloret, A. (2010). Why women have more Alzheimer's disease than men: Gender and mitochondrial toxicity of amyloidbeta peptide. Journal of Alzheimer's Disease, 20(Suppl 2), S527-S533. doi:10.3233/JAD-2010-100501
58. Wechsler, D. (1987). Wechsler Memory Scale - Revised edition. San Antonio, TX: The Psychological Corporation
59. Wechsler, D. (1997). WAIS-III: Wechsler Adult Intelligence Scale - 3rd edition. San Antonio, TX: The Psychological Corporation
60. Wechsler, D. (1999). Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation
61. Wilkinson, G. (1993). Wide Range Achievement Test Administration Manual (3rd ed). Wilmington, Delaware: Wide Range Incorporated
62. Wirth, M., Madison, C.M., Rabinovici, G.D., Oh, H., Landau, S.M. Jagust, W.J. (2013). Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not beta-Amyloid in cognitively normal older individuals. Journal of Neuroscience, 33(13), 5553-5563. doi:10.1523/JNEUROSCI.4409-12.2013
63. Wirth, M., Oh, H., Mormino, E.C., Markley, C., Landau, S.M. Jagust, W.J. (2013). The effect of amyloid beta on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimer's Dementia. doi:10.1016/j.jalz.2012.10.012
64. Xu, G., McLaren, D.G., Ries, M.L., Fitzgerald, M.E., Bendlin, B.B., Rowley, H.A.,yJohnson, S.C. (2009). The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain, 132(Pt 2), 383-391. doi:10.1093/brain/awn254
65. Zhou, X., Obuchowski, N. McClish, D. (2011). Statistical methods in Diagnostic medicine (2nd ed). Hoboken, NJ: John Wiley Sons, Inc.